Boston Scientific Corp (BSX.N)

BSX.N on New York Stock Exchange

17.50USD
10:45pm IST
Change (% chg)

$-0.25 (-1.41%)
Prev Close
$17.75
Open
$17.75
Day's High
$17.79
Day's Low
$17.31
Volume
687,565
Avg. Vol
2,797,915
52-wk High
$18.17
52-wk Low
$11.11

BSX.N

Chart for BSX.N

About

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company operates in three segments, including Cardiovascular, Rhythm Management and MedSurg. The Company’s cardiovascular segment includes Interventional Cardiology and... (more)

Overall

Beta: 1.10
Market Cap(Mil.): $23,770.46
Shares Outstanding(Mil.): 1,339.18
Dividend: --
Yield (%): --

Financials

Search Stocks

UPDATE 2-Boston Scientific gets U.S. OK for Watchman heart device

March 13 - Boston Scientific Corp said on Friday that the U.S. Food and Drug Administration approved its device to prevent stroke in patients with a dangerous irregular heart rhythm known as atrial fibrillation (AF).

14 Mar 2015

Boston Scientific gets U.S. OK for Watchman heart device

- Boston Scientific Corp said on Friday that the U.S. Food and Drug Administration approved its device to prevent stroke in patients with a dangerous irregular heart rhythm known as atrial fibrillation (AF).

14 Mar 2015

Boston Scientific wins U.S. approval for atrial fibrillation device

March 13 - Boston Scientific Corp said the U.S. Food and Drug Administration on Friday approved its device to prevent stroke in patients with a dangerous irregular heart rhythm known as atrial fibrillation.

14 Mar 2015

EU court rules Boston Scientific must pay pacemaker replacement surgery

BRUSSELS - U.S. medical device maker Boston Scientific Corp's German arm is liable for the cost of operations to replace potentially defective pacemakers, Europe's top court ruled on Thursday.

05 Mar 2015

EU court rules Boston Scientific must pay pacemaker replacement surgery

BRUSSELS, March 5 - U.S. medical device maker Boston Scientific Corp's German arm is liable for the cost of operations to replace potentially defective pacemakers, Europe's top court ruled on Thursday.

05 Mar 2015

Boston Scientific to buy Endo's urology portfolio for $1.65 billion

- Medical device maker Boston Scientific Corp said it will buy Endo International Plc's American Medical Systems' men's and prostate health business for up to $1.65 billion.

02 Mar 2015

UPDATE 1-Boston Scientific to buy Endo's urology portfolio for $1.65 bln

March 2 - Medical device maker Boston Scientific Corp said it will buy Endo International Plc's American Medical Systems' men's and prostate health business for up to $1.65 billion.

02 Mar 2015

Boston Scientific to buy Endo's urology portfolio for up to $1.65 bln

March 2 - Boston Scientific Corp said it will acquire Endo International Plc's American Medical Systems urology portfolio for up to $1.65 billion.

02 Mar 2015

Deals of the day- Mergers and acquisitions

Feb 24 - The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Tuesday:

25 Feb 2015

Boston Scientific near deal to buy Endo's device unit: sources

NEW YORK - Boston Scientific Corp is close to buying Endo International PLC's AMS medical device unit, a deal that could value the business at around $2 billion, according to people familiar with the matter.

24 Feb 2015

Competitors

  Price Chg
Abbott Laboratories (ABT.N) $45.76 -0.57
St. Jude Medical, Inc. (STJ.N) $65.09 -0.31

Earnings vs. Estimates

Search Stocks